Guardion’s Lumega-Z Formula Associated with Improved Vision in Patients with Severe Glaucoma
Guardion Health Sciences, Inc. Receives Official Trademark Registrations in China
Results of Lumega-Z Data to be Presented at ARVO
Guardion Health Sciences, Inc. Announces Pricing of Initial Public Offering
Guardion Health Sciences Receives Methods Patents to Standardize Vision Testing
Guardion Health Sciences Exhibiting at Caribbean Eye Meeting
Guardion Health Sciences Closes $5 Million Common Equity Financing
Guardion Health Sciences acquires VectorVision
Guardion Health Sciences announces completion of Series B funding round, raising over $3 million
International Carotenoid Society honors Advisory Board Members with Fellowship Awards
Guardion Health Sciences signs Letter of Intent to acquire VectorVision
Guardion Health Sciences, Inc. completes registration with SEC, becomes a Public Reporting Company
Guardion Health Sciences receives patent for its diagnostic device, the MapcatSF
P Dee G Stephenson, M.D. joins Guardion Health Sciences Medical Advisory Board
Bridgitte Shen Lee, O.D. joins Guardion Health Sciences Medical Advisory Board
Guardion Health Sciences Files Form S-1 Registration Statement under the Securities Act of 1933
Macular pigment specialists, Guardion Health Sciences appoints Gordon Bethwaite as Vice President
Col (R) Donald A. Gagliano, MD, MHA, FACHE, CPC joins Guardion’s Science Advisory Board
Macular Carotenoids Conference 2013
GHS Scientists to Present at the Macular Carotenoids & AMD Conference 2011